Home
/
NeuroPace Inc
/
Financials
/
Quarterly
NeuroPace Inc — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that NeuroPace Inc filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$27.35M
Nov 4, 2025
Q2
2025
Jun 30, 2025
$23.52M
Aug 12, 2025
Q1
2025
Mar 31, 2025
$22.52M
May 13, 2025
Q3
2025
Sep 30, 2024
$21.06M
Nov 4, 2025
Q2
2025
Jun 30, 2024
$19.26M
Aug 12, 2025
Q1
2025
Mar 31, 2024
$18.12M
May 13, 2025
Q3
2024
Sep 30, 2023
$16.43M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$16.51M
Aug 13, 2024
Q1
2024
Mar 31, 2023
$14.47M
May 8, 2024
Q3
2023
Sep 30, 2022
$11.16M
Nov 6, 2023
Q2
2023
Jun 30, 2022
$10.20M
Aug 8, 2023
Q1
2023
Mar 31, 2022
$11.37M
May 4, 2023
Q3
2022
Sep 30, 2021
$10.34M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$12.63M
Aug 11, 2022
Q1
2022
Mar 31, 2021
$11.22M
May 12, 2022
Q3
2021
Sep 30, 2020
$12.77M
Nov 10, 2021
Q2
2021
Jun 30, 2020
$7.64M
Aug 12, 2021
Q1
2021
Mar 31, 2020
$9.98M
Jun 3, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($3.50M)
Nov 4, 2025
Q2
2025
Jun 30, 2025
($8.65M)
Aug 12, 2025
Q3
2025
Jun 30, 2025
($8.65M)
Nov 4, 2025
Q1
2025
Mar 31, 2025
($6.59M)
May 13, 2025
Q2
2025
Mar 31, 2025
($6.59M)
Aug 12, 2025
Q3
2025
Mar 31, 2025
($6.59M)
Nov 4, 2025
Q3
2025
Sep 30, 2024
($5.45M)
Nov 4, 2025
Q3
2025
Jun 30, 2024
($7.51M)
Nov 4, 2025
Q2
2025
Jun 30, 2024
($7.51M)
Aug 12, 2025
Q2
2025
Mar 31, 2024
($8.93M)
Aug 12, 2025
Q3
2025
Mar 31, 2024
($8.93M)
Nov 4, 2025
Q1
2025
Mar 31, 2024
($8.93M)
May 13, 2025
Q3
2024
Sep 30, 2023
($7.26M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($9.12M)
Aug 13, 2024
Q3
2024
Jun 30, 2023
($9.12M)
Nov 12, 2024
Q3
2024
Mar 31, 2023
($10.38M)
Nov 12, 2024
Q1
2024
Mar 31, 2023
($10.38M)
May 8, 2024
Q2
2024
Mar 31, 2023
($10.38M)
Aug 13, 2024
Q3
2023
Sep 30, 2022
($11.79M)
Nov 6, 2023
Q2
2023
Jun 30, 2022
($12.69M)
Aug 8, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($2.60M)
Nov 4, 2025
Q2
2025
Jun 30, 2025
($6.82M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($5.15M)
May 13, 2025
Q3
2025
Sep 30, 2024
($4.24M)
Nov 4, 2025
Q2
2025
Jun 30, 2024
($6.23M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($7.55M)
May 13, 2025
Q3
2024
Sep 30, 2023
($5.95M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($7.85M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($8.32M)
May 8, 2024
Q3
2023
Sep 30, 2022
($10.20M)
Nov 6, 2023
Q2
2023
Jun 30, 2022
($10.97M)
Aug 8, 2023
Q1
2023
Mar 31, 2022
($9.76M)
May 4, 2023
Q3
2022
Sep 30, 2021
($6.24M)
Nov 8, 2022
Q2
2022
Jun 30, 2021
($4.61M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($3.87M)
May 12, 2022
Q3
2021
Sep 30, 2020
($1.17M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($3.45M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($5.46M)
Jun 3, 2021